|
HY-101879-1mL
|
MedChemexpress LLC
|
Acridine Orange (hydrochloride) [CAS 65-61-2] (10mM in DMSO)
|
|
|
|
|
HY-D0938-10mg
|
MedChemexpress LLC
|
CFDA-SE [CAS 150347-59-4]
|
|
|
|
|
HY-D0938-5mg
|
MedChemexpress LLC
|
CFDA-SE [CAS 150347-59-4]
|
|
|
|
|
HY-R01462-20nmol
|
MedChemexpress LLC
|
hsa-miR-488-3p mimic
|
|
Cancer-programmed cell death
|
|
|
HY-R01462-5nmol
|
MedChemexpress LLC
|
hsa-miR-488-3p mimic
|
|
Cancer-programmed cell death
|
|
|
HY-R01463-20nmol
|
MedChemexpress LLC
|
hsa-miR-488-5p mimic
|
|
Cancer-programmed cell death
|
|
|
HY-R01463-5nmol
|
MedChemexpress LLC
|
hsa-miR-488-5p mimic
|
|
Cancer-programmed cell death
|
|
|
HY-15096-1mg
|
MedChemexpress LLC
|
MKT-077 [CAS 147366-41-4]
|
|
Cancer-programmed cell death
|
|
|
HY-15096-10mg
|
MedChemexpress LLC
|
MKT-077 [CAS 147366-41-4]
|
|
Cancer-programmed cell death
|
|
|
HY-15096-100mg
|
MedChemexpress LLC
|
MKT-077 [CAS 147366-41-4]
|
|
Cancer-programmed cell death
|
|
|
HY-15096-5mg
|
MedChemexpress LLC
|
MKT-077 [CAS 147366-41-4]
|
|
Cancer-programmed cell death
|
|
|
HY-15096-50mg
|
MedChemexpress LLC
|
MKT-077 [CAS 147366-41-4]
|
|
Cancer-programmed cell death
|
|
|
HY-15096-1mL
|
MedChemexpress LLC
|
MKT-077 [CAS 147366-41-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-R03218-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p mimic
|
|
Cancer-programmed cell death
|
|
|
HY-R03218-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p mimic
|
|
Cancer-programmed cell death
|
|
|
HY-R03219-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p mimic
|
|
Cancer-programmed cell death
|
|
|
HY-R03219-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p mimic
|
|
Cancer-programmed cell death
|
|
